Cargando…

Valyl: Valerianic Acid Diethylamid

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	1902
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729684/

Ejemplares similares

Valyl
por: Ammelburg, A.
Publicado: (1905)

Valyl benzyl ester chloride
por: Dutkiewicz, Grzegorz, et al.
Publicado: (2010)

Brovalol, a Distinct Advance in Valerian Therapy
Publicado: (1910)

Valerianate of Quinia
Publicado: (1845)

Lysergic Acid Diethylamide and Mescaline in Experimental Psychiatry
por: Freedman, Daniel X.
Publicado: (1957)

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects
por: Dolder, Patrick C., et al.
Publicado: (2017)

Valerianate of Ammonia for Epilepsy
Publicado: (1858)

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants
por: Holze, Friederike, et al.
Publicado: (2020)

Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans
por: Kanen, Jonathan W., et al.
Publicado: (2023)

Lysergic acid diethylamide (LSD) promotes social behaviour through 5-HT(2A) and ampa in the medial prefrontal cortex (MPFC)
por: Markopoulos, A., et al.
Publicado: (2021)

Treatment of Neuralgia, by the Valerianate of Ammonia
Publicado: (1857)

Valerianate of Ammonia in the Treatment of Neuralgia
por: Hay, W.
Publicado: (1857)

Structural diversity and phylogenetic distribution of valyl tRNA-like structures in viruses
por: Sherlock, Madeline E., et al.
Publicado: (2021)

The anxiolytic effects of a Valerian extract is based on Valerenic acid
por: Becker, Axel, et al.
Publicado: (2014)

Valerian: No Evidence for Clinically Relevant Interactions
por: Kelber, Olaf, et al.
Publicado: (2014)

Ethereal Tinct: Valerian in Convulsions in Children
por: Hardee, B. W.
Publicado: (1860)

Ethereal Tincture of Valerian in Convulsions of Children
por: Byrd, H. L.
Publicado: (1860)

Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review
por: Więckiewicz, Gniewko, et al.
Publicado: (2021)

Lysergic acid diethylamide induces increased signalling entropy in rats’ prefrontal cortex
por: Savino, Aurora, et al.
Publicado: (2021)

The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity
por: Bedford, Peter, et al.
Publicado: (2023)

Caenorhabditis elegans glp-4 Encodes a Valyl Aminoacyl tRNA Synthetase
por: Rastogi, Suchita, et al.
Publicado: (2015)

The effect of cephalexin in influencing the pharmacokinetics of a novel drug – 5′-valyl-cytarabine hydrochloride
por: Song, Xiaotong, et al.
Publicado: (2017)

Analgesic Effect of Valerian Root and Turnip Extracts
por: Zare, Afshin, et al.
Publicado: (2018)

An Alternative Cause of Encephalopathy: Valerian Root Overdose
por: Freitas, Corina, et al.
Publicado: (2021)

d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology
por: De Gregorio, Danilo, et al.
Publicado: (2016)

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers
por: Ramaekers, Johannes G, et al.
Publicado: (2020)

Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
por: Gasser, Peter, et al.
Publicado: (2014)

The Effects of Valerian Root on Hot Flashes in Menopausal Women
por: Mirabi, Parvaneh, et al.
Publicado: (2013)

Case of Epilepsy of Twelve Years Duration Cured by Valerian
por: Gairdner, John
Publicado: (1828)

Biallelic mutations in valyl-tRNA synthetase gene VARS are associated with a progressive neurodevelopmental epileptic encephalopathy
por: Friedman, Jennifer, et al.
Publicado: (2019)

PM361. The hallucinogen D-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT(1A), D(2) and TAAR(1) receptors
por: Gregorio, Danilo De, et al.
Publicado: (2016)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers
por: Family, Neiloufar, et al.
Publicado: (2019)

Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission
por: De Gregorio, Danilo, et al.
Publicado: (2021)

Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)
por: Kopra, Emma I, et al.
Publicado: (2022)

Synergistic potentiation of anti-anxiety activity of valerian and alprazolam by liquorice
por: Bhatt, Chaitanya, et al.
Publicado: (2013)

The effects of Valerian on sleep spindles in a model of neuropathic pain
por: Soltani, Ashkan, et al.
Publicado: (2021)

Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications
por: Shi, Fengqin, et al.
Publicado: (2021)

Multiple pathways for the formation of the γ-glutamyl peptides γ-glutamyl-valine and γ- glutamyl-valyl-glycine in Saccharomyces cerevisiae
por: Sofyanovich, Olga A., et al.
Publicado: (2019)

Self-inflicted neck wounds under influence of lysergic acid diethylamide: A case report and literature review
por: Le Daré, Brendan, et al.
Publicado: (2020)

Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020
por: Kopra, Emma I, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_93orqt2p365jjvdolumhemkfjc